Heart association advises against HRT for heart protectionBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7307.252/c (Published 04 August 2001) Cite this as: BMJ 2001;323:252
- Deborah Josefson
- San Francisco
The American Heart Association has issued revised guidelines on hormone replacement therapy (HRT) for postmenopausal women.
The new guidelines reverse previous recommendations and advise against the use of hormone replacement therapy for cardiovascular protection alone in postmenopausal women (Circulation 2001;104:499-503).
The revised recommendations were issued because of conflicting evidence about combined oestrogen and progestogen (known as progestin in the United States) therapy and its effects on the heart. Traditionally, hormone replacement therapy was believed to be good for the heart, and in recent years it has been prescribed not only to ward off menopausal symptoms, but also …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial